Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
04/1998
04/01/1998EP0832078A1 N-hydroxyureas as antiinflammatory agents
04/01/1998EP0832076A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
04/01/1998EP0832071A1 1,3-dihydro-2h-imidazol-2-one derivatives having pde iv and cytokinin inhibiting activity
04/01/1998EP0832063A1 Novel vitamin d derivatives with c-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments
04/01/1998EP0832057A1 Diaromatic propynyl or dienyl compounds
04/01/1998EP0831917A2 Immunotoxins specific for cd80 and cd86 expressing cells
04/01/1998EP0831912A1 Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
04/01/1998EP0831906A1 Treatment of t cell mediated autoimmune disorders
04/01/1998EP0831893A1 Regulation of cytokine synthesis and release
04/01/1998EP0831889A1 Use of il-13 to induce 15-lipoxygenase
04/01/1998EP0831875A1 Methods of inhibiting phagocytosis
04/01/1998EP0831871A1 Relaxin-like factor and methods and uses thereof
04/01/1998EP0831854A1 Oligonucleotides having phosphorothioate linkages of high chiral purity
04/01/1998EP0831847A2 Use of di-beta-d-glucopyranosylamine compounds for controlling inflammatory reactions, and method of synthesis
04/01/1998EP0831840A1 Use of non-steroidal anti-inflammatory agents to improve the physiological compatibility of particular pharmaceutical preparations
04/01/1998EP0831831A1 Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of her-2 autophosphorylation properties
04/01/1998EP0831830A1 Imidazole compounds
04/01/1998EP0831817A1 Antigen-processing cell-targeted conjugates
04/01/1998EP0831811A1 Methods of treating microbial infections
04/01/1998EP0831802A1 Treatment of a trabecular meshwork whose cells are subject ot inhibition of cell division with non-steroidal anti-inflammatory drugs
04/01/1998EP0831801A1 Non-steroidal anti-inflammatory drugs for the cyto-protection of the trabecular meshwork
04/01/1998EP0831800A1 ARYLSULFONYLAMINOBENZENE DERIVATIVES AND THE USE THEREOF AS FACTOR Xa INHIBITORS
04/01/1998EP0831791A1 Delivery of drugs to the lower gi tract
04/01/1998EP0831789A1 Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions
04/01/1998EP0741707B1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS
04/01/1998EP0625987B1 Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
04/01/1998EP0572451B1 Novel steroid esters
04/01/1998CN1177927A Extracts of shark cartilage, process of production and uses thereof
04/01/1998CN1177480A Preparation absorbed through skin, containing woluoke kinds of medicine
03/1998
03/31/1998US5733939 Fluorocarbons as anti-inflammatory agents
03/31/1998US5733923 Secretory pancreatic phospholipase a2
03/31/1998US5733921 Isothiazolone compounds
03/31/1998US5733901 Administering to treat skin and respiratory system disorders, inflammatory disorders of the bowel, and allergic rhinitis/conjunctivitis
03/31/1998US5733876 Method of inhibiting angiogenesis
03/31/1998US5733872 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
03/31/1998US5733578 Directly compressible high load acetaminophen formulations
03/26/1998WO1998012221A1 Peptide as diagnostic and therapeutic agent for autoimmune diseases
03/26/1998WO1998012211A1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
03/26/1998WO1998012210A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
03/26/1998WO1998012177A1 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
03/26/1998WO1998012176A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
03/26/1998WO1998011912A1 Pharmaceutical formulations of corticotropin releasing factor having improved stability in liquid form
03/26/1998WO1998011908A1 Combination therapy for treatment of arthritic diseases
03/26/1998WO1998011887A2 Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides
03/26/1998DE19704301C1 Human endoglin gene promoter
03/26/1998DE19639103A1 DNA construct with inhibitory mutation and corrective mutation
03/26/1998CA2266849A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators
03/26/1998CA2266639A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
03/25/1998EP0831090A1 N-substituted cyclic amines, process for their preparation and pharmaceutical compositions containing them
03/25/1998EP0830455A1 Position-specific integration of vector constructs into eukaryotic genomes mediated by a chimeric integrase protein
03/25/1998EP0830374A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
03/25/1998EP0830347A1 Novel substituted piperazine derivatives having tachykinin receptor antagonists activity
03/25/1998EP0830130A1 Tnf-alpha converting enzyme
03/25/1998EP0802791A4 3,3-(disubstituted)cyclohexan-1-ylidine acetate dimers and related compounds
03/25/1998EP0799186A4 1,4,4-(trisubstituted)cyclohex-1-ene dimers and related compounds
03/25/1998EP0799185A4 1,3,3-(trisubstituted)cyclohexane dimers and related compounds
03/25/1998EP0799184A4 4,4-(disubstituted)cyclohexan-1-ol dimers and related compounds
03/25/1998EP0799182A4 3,3-(disubstituted)cyclohexan-1-ol dimers and related compounds
03/25/1998EP0799181A4 3,3-(disubstituted)cyclohexan-1-carboxylate dimers and related compounds
03/25/1998EP0799036A4 4,4-(disubstituted)cyclohexan-1-ylidine acetate dimers and related compounds
03/25/1998EP0799031A4 1,4,4-(trisubstituted)cyclohexane dimers and related compounds
03/25/1998CN1177343A Cell adhesion inhibitors
03/25/1998CN1177299A Certain 1, 4, 5 -tri- substituted imidazole compounds useful as cytokine
03/25/1998CN1176826A Cyclosporin-containing topical pharmaceutical compostion
03/25/1998CN1176825A Medicated wine for sauna bath
03/25/1998CN1037841C Process for preparing substituted 4 -phenyl -4 - piperidinecarboxamide having local anaesthetis and analgestic effect
03/24/1998US5731447 Process for preparing 16α-methyl-steroids
03/24/1998US5731441 Hydroxamic acid derivatives with tricyclic substitution
03/24/1998US5731432 Inhibitors of adenosine monophosphate deaminase
03/24/1998US5731332 Leukotriene antagonists; antiinflammatory agents, antiallergens
03/24/1998US5731321 Endothelin receptor antagonists
03/24/1998US5731319 Antiallergens; antihistamines
03/24/1998US5731299 Phosphonosulfonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
03/24/1998US5731293 Enzyme inhibitors
03/24/1998US5731286 Cyclic neurokinin A antagonists
03/24/1998US5731149 Antibiotic cryptdin peptides and methods of their use
03/24/1998US5730998 Administering substance p antagonist
03/24/1998CA2211008A1 Nucleic acid constructs containing hybrid promoters for use in gene therapy
03/24/1998CA1339777C Superoxide dismutase polymers
03/19/1998WO1998011236A1 Aspartic protease
03/19/1998WO1998011223A1 Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr)
03/19/1998WO1998011129A1 C-TERMINAL MODIFIED (N-SUBSTITUTED)-2-INDOLYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES
03/19/1998WO1998011128A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production
03/19/1998WO1998011109A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes
03/19/1998WO1998011095A1 Substituted 2-pyrimidineamines, their preparation and their use as proteine kinase inhibitors
03/19/1998WO1998010783A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions
03/19/1998WO1998010764A1 Pharmaceutical composition for treating viral diseases
03/19/1998WO1998010746A1 Compositions and methods for topical application of therapeutic agents
03/19/1998WO1998006387A3 Oral composition comprising 5-aminosalicylic acid
03/19/1998CA2265928A1 C-terminal modified (n-substituted)-2-indolyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
03/19/1998CA2265927A1 Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr)
03/19/1998CA2265542A1 Pharmaceutical composition for treating viral diseases
03/19/1998CA2264748A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions
03/19/1998CA2264541A1 Human protein kinases
03/19/1998CA2262818A1 Modified amino acids, pharmaceuticals containing these compounds and methods for their production
03/19/1998CA2237314A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes
03/18/1998EP0829481A1 Morphinan hydroxamic acid compounds
03/18/1998EP0829480A2 Tetrazolyl-substituted quinuclidines as substance P antagonists
03/18/1998EP0829470A1 2-Cyano-3,5-dihydroxy-hex-2-ene carboxamide derivatives, process for their preparation and their use as medicaments
03/18/1998EP0828849A1 High-affinity oligonucleotide ligands to growth factors
1 ... 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 ... 1272